MedPath

Effect of Magnesium Supplement in Early Pregnancy After ICSI

Phase 3
Conditions
ICSI
Interventions
Drug: Placebo Oral Tablet
Registration Number
NCT03398031
Lead Sponsor
Ain Shams University
Brief Summary

Daily supplement of magnesium after biochemical diagnosis of pregnancy in females pregnant after ICSI and through out 1st trimester

Detailed Description

a fall of magnesium levels at 2-3 weeks of gestation. This drop of magnesium concentration is larger following IVF as compared to spontaneous pregnancies.

so magnesium supplement start after biochemical diagnosis of pregnancy and throughout the 1st trimester

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
180
Inclusion Criteria
  • age 25_38 years

  • BMI 25_30

    • females pregnant after ICSI after biochemical diagnosis of pregnancy
Exclusion Criteria
  • females with poor ovarian reserve and poor responders

    • abnormality in uterine cavity detected by hysteroscopic evaluation pre ICSI and not treated
    • hydrosalpinx

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Magnesium supplementMagnesium Oxide90 female pregnant after ICSI after biochemical diagnosis of pregnancy will receive 500 mg magnesium supplement
placeboPlacebo Oral Tablet90 female pregnant after ICSI after biochemical diagnosis of pregnancy will receive placebo oral tablet
Primary Outcome Measures
NameTimeMethod
1st trimesteric abortion13 week of gestation

Either spontaneous or missed abortion

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

AinShams university maternity hospital

🇪🇬

Cairo, Abbassya, Egypt

AinShams university maternity hospital
🇪🇬Cairo, Abbassya, Egypt
ahmed m Abbas, MD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.